ru 24926 has been researched along with mr 2266 in 1 studies
Studies (ru 24926) | Trials (ru 24926) | Recent Studies (post-2010) (ru 24926) | Studies (mr 2266) | Trials (mr 2266) | Recent Studies (post-2010) (mr 2266) |
---|---|---|---|---|---|
30 | 0 | 0 | 176 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Degryse, M; Fortin, M; Hunt, PF; Petit, F | 1 |
1 other study(ies) available for ru 24926 and mr 2266
Article | Year |
---|---|
The dopamine D2 agonists RU 24213 and RU 24926 are also kappa-opioid receptor antagonists.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Dopamine Agents; Guinea Pigs; In Vitro Techniques; Male; Molecular Structure; Morphine; Narcotic Antagonists; Phenethylamines; Pyrrolidines; Rabbits; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1991 |